INBS adds 33 new customer accounts in Q1 FY2026, up 50% YoY; total active accounts exceed 480

INTELLIGENT BIO SOLUTIONS INC.

Added 33 new customer accounts in fiscal Q1 ended Sept 30, 2025, a 50% increase YoY.
Total active accounts reached over 480; growth driven by maritime, transport, logistics, and new government sector.
91% of new accounts were first-time adopters; 9% expanded use within existing organizations.
Strong UK growth supported by distributor expansion across Europe and Middle East.
Global drug screening market projected at $17.1B by 2029, 15% CAGR, supporting INBS's expansion.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.